IRIS Accounts Production v23.2.0.158 14126578 director 24.5.22 31.5.23 31.5.23 false true false false true false A ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure141265782022-05-23141265782023-05-31141265782022-05-242023-05-31141265782022-05-2314126578ns16:EnglandWales2022-05-242023-05-3114126578ns15:PoundSterling2022-05-242023-05-3114126578ns11:Director12022-05-242023-05-3114126578ns11:PrivateLimitedCompanyLtd2022-05-242023-05-3114126578ns11:SmallEntities2022-05-242023-05-3114126578ns11:AuditExempt-NoAccountantsReport2022-05-242023-05-3114126578ns11:SmallCompaniesRegimeForDirectorsReport2022-05-242023-05-3114126578ns11:SmallCompaniesRegimeForAccounts2022-05-242023-05-3114126578ns11:FullAccounts2022-05-242023-05-3114126578ns11:OrdinaryShareClass12022-05-242023-05-3114126578ns6:CurrentFinancialInstruments2023-05-3114126578ns6:ShareCapital2023-05-3114126578ns6:RetainedEarningsAccumulatedLosses2023-05-3114126578ns11:RegisteredOffice2022-05-242023-05-3114126578ns6:ComputerEquipment2022-05-242023-05-3114126578ns6:ComputerEquipment2023-05-3114126578ns11:OrdinaryShareClass12023-05-3114126578ns11:Director112022-05-2314126578ns11:Director112022-05-242023-05-3114126578ns11:Director112023-05-31
REGISTERED NUMBER: 14126578 (England and Wales)















Unaudited Financial Statements

for the Period 24th May 2022 to 31st May 2023

for

AKC Medical Limited

AKC Medical Limited (Registered number: 14126578)






Contents of the Financial Statements
for the Period 24th May 2022 to 31st May 2023




Page

Balance Sheet 1

Notes to the Financial Statements 2


AKC Medical Limited (Registered number: 14126578)

Balance Sheet
31st May 2023

Notes £    £   
FIXED ASSETS
Tangible assets 4 1,118

CURRENT ASSETS
Cash at bank 6,938

CREDITORS
Amounts falling due within one year 5 2,389
NET CURRENT ASSETS 4,549
TOTAL ASSETS LESS CURRENT
LIABILITIES

5,667

CAPITAL AND RESERVES
Called up share capital 6 100
Retained earnings 5,567
SHAREHOLDERS' FUNDS 5,667

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31st May 2023.

The members have not required the company to obtain an audit of its financial statements for the period ended 31st May 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 23rd February 2024 and were signed by:





Dr A Chan - Director


AKC Medical Limited (Registered number: 14126578)

Notes to the Financial Statements
for the Period 24th May 2022 to 31st May 2023

1. COMPANY INFORMATION

AKC Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 14126578

Registered office: First Floor
49 Peter Street
Manchester
United Kingdom
M2 3NG

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 25% on cost

Tangible fixed assets are included at cost less depreciation and impairment. Depreciation has been computed to write off the cost of tangible fixed assets over their expected useful life.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 .

AKC Medical Limited (Registered number: 14126578)

Notes to the Financial Statements - continued
for the Period 24th May 2022 to 31st May 2023

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
Additions 1,309
At 31st May 2023 1,309
DEPRECIATION
Charge for period 191
At 31st May 2023 191
NET BOOK VALUE
At 31st May 2023 1,118

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Tax 1,364
Directors' current accounts 431
Accrued expenses 594
2,389

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal
value: £   
100 A ordinary 1 100

On incorporation 100 Ordinary A shares, each of £1 were allotted, called up and fully paid at par.

Ordinary A Shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

7. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the period ended 31st May 2023:

£   
Dr A Chan
Balance outstanding at start of period -
Amounts advanced 1,809
Amounts repaid (2,240 )
Amounts written off -
Amounts waived -
Balance outstanding at end of period (431 )

The loan is repayable on demand and no interest was charged during the period.

8. ULTIMATE CONTROLLING PARTY

The controlling party is Dr A Chan.